| 04/22/2026 3:30 PM | Pliant Therapeutics (1746473) Filer | Form DEF 14A | |
| 04/22/2026 3:31 PM | Pliant Therapeutics (1746473) Filer | Form DEFA14A | |
| 04/22/2026 3:33 PM | Pliant Therapeutics (1746473) Filer | Form ARS | |
| 04/17/2026 3:42 PM | Cheung Lily (1962207) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 3:42 PM | Coulie Bernard (1808895) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 3:42 PM | Cummings Keith Lamont (1809204) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 3:42 PM | Kuo Minnie (2101360) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 3:30 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/06/2026 11:15 PM | Pliant Therapeutics (1746473) Filer | Form EFFECT | |
| 03/11/2026 3:32 PM | Pliant Therapeutics (1746473) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/17/2026 3:29 PM | Pliant Therapeutics (1746473) Subject Point72 Asset Management, L.P. (1603466) Filed by | Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for PLRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/09/2026 5:13 PM | CITADEL ADVISORS LLC (1423053) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G | |
| 01/30/2026 6:11 PM | CITADEL ADVISORS LLC (1423053) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G | |
| 01/26/2026 3:36 PM | Coulie Bernard (1808895) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:36 PM | Cheung Lily (1962207) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:36 PM | Kuo Minnie (2101360) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:36 PM | Cummings Keith Lamont (1809204) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:38 PM | Kuo Minnie (2101360) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:38 PM | Coulie Bernard (1808895) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:38 PM | Cheung Lily (1962207) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:46 PM | Cummings Keith Lamont (1809204) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 6:02 PM | CITADEL ADVISORS LLC (1423053) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G | |
| 12/22/2025 4:02 PM | Kuo Minnie (2101360) Reporting Pliant Therapeutics (1746473) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 12/16/2025 4:05 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/08/2025 3:41 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 7:22 AM | Deep Track Capital, LP (1856083) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G/A | |
| 11/06/2025 3:09 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/24/2025 3:32 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/04/2025 4:13 PM | Pliant Therapeutics (1746473) Subject Point72 Asset Management, L.P. (1603466) Filed by | Form SCHEDULE 13G | |
| 08/14/2025 7:49 AM | Deep Track Capital, LP (1856083) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G/A | |
| 08/06/2025 1:12 PM | MORGAN STANLEY (895421) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G | |
| 07/17/2025 7:12 PM | BlackRock, Inc. (2012383) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G/A | |
| 06/09/2025 7:42 PM | CROWELL GAYLE A (1250893) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 7:43 PM | Huh Hoyoung (1401267) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 7:43 PM | Pliant Therapeutics (1746473) Issuer PYOTT DAVID E I (1051578) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 7:43 PM | Cline Darren S (1633639) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 7:43 PM | Krognes Steve E. (1666236) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 7:44 PM | Curnutte John T (1574589) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 7:44 PM | MCCOURT Thomas A (1478448) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 7:44 PM | Knobil Katharine (1768011) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 7:44 PM | Bruhn Suzanne Louise (1517790) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 06/09/2025 4:29 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2025 3:39 PM | Paradigm Biocapital Advisors LP (1855655) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G/A | |
| 05/14/2025 9:45 AM | Pliant Therapeutics (1746473) Subject PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by | Form SCHEDULE 13G/A | |